Publications by authors named "Sandra Rea"

Claim this Profile
M
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, Gianluigi Ferretti, Simona Gasparro, Sandra Rea

Biol Direct· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors.
Alessio Annovazzi, Sandra Rea, Daria Maccora, Laura Pizzuti, Gianluigi Ferretti

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Prognostic value of total metabolic tumour volume and therapy-response assessment by [F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors.
Alessio Annovazzi, Virginia Ferraresi, Sandra Rea, Michelangelo Russillo, Davide Renna

Eur Radiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of total metabolic tumour volume and therapy-response assessment by [F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors.
Alessio Annovazzi, Virginia Ferraresi, Sandra Rea, Michelangelo Russillo, Davide Renna

Eur Radiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone density and genomic analysis unfold cold adaptation mechanisms of ancient inhabitants of Tierra del Fuego.
Mikiko Watanabe, Renata Risi, Mary Anne Tafuri, Valentina Silvestri, Daniel D'Andrea, Sandra Rea

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study Assessing the Post-Prostatectomy Detection Rate of a Presumed Local Failure at mpMR with Either CuCl or CuPSMA PET/CT.
Adriana Faiella, Rosa Sciuto, Diana Giannarelli, Marta Bottero, Alessia Farneti, Sandra Rea

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of dosimetry and biological effects in metastatic castration-resistant prostate cancer (mCRPC) patients treated with Ra: first in human study.
Rosa Sciuto, Sandra Rea, Sara Ungania, Antonella Testa, Valentina Dini

J Exp Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis of the Iliac Vein Detected by 64Cu-Prostate-Specific Membrane Antigen (PSMA) PET/CT.
Salvatore Annunziata, Sandra Rea, Luisa Romano, Costanza Mazzone, Silvia Di Traglia

Clin Nucl Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Clinical Impact of 18F-FDG PET/CT in Staging and Restaging Soft-Tissue Sarcomas of the Extremities and Trunk: Mono-Institutional Retrospective Study of a Sarcoma Referral Center.
Alessio Annovazzi, Sandra Rea, Carmine Zoccali, Rosa Sciuto, Jacopo Baldi

J Clin Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-time 18F-FDG PET/CT for the detection of liver metastases in breast cancer.
Alessio Annovazzi, Sandra Rea, Patrizia Vici, Alessandra Fabi, Rosa Sciuto

Nucl Med Commun· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.
Giuseppe Simone, Giovanni Battista Di Pierro, Rocco Papalia, Rosa Sciuto, Sandra Rea

World J Urol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma.
Francesco Pisani, Rosa Sciuto, Maria Laura Dessanti, Diana Giannarelli, Ramy Kayal, Sandra Rea

Exp Hematol Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, mass, and glucose-uptake activity of ¹⁸F-FDG-detected brown adipose tissue in humans living in a temperate zone of Italy.
Agnese Persichetti, Rosa Sciuto, Sandra Rea, Sabrina Basciani, Carla Lubrano

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
Lidia Strigari, Rosa Sciuto, Sandra Rea, Livio Carpanese, Giuseppe Pizzi

J Nucl Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
Rosa Sciuto, Anna Festa, Sandra Rea, Rosella Pasqualoni, Serenella Bergomi

J Nucl Med· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis